Gene · 407020
MIR28: microRNA 28
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. MIR28: microRNA 28. Genes, record 407020. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407020
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants572
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR28 papers | Newest fiscal year |
|---|---|---|---|
| P50CA127001 | SPORE in Brain Cancer | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30AI117970 | District of Columbia Center for AIDS Research | 2 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 2 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30CA134274 | UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT | 2 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 2 | 2025 |
| R01DE018304 | ART Modulation of Viral Pathogenesis | 2 | 2025 |
| R01ES027778 | Mechanism for arsenic induced carcinogenesis | 2 | 2025 |
1 to 10 of 572Source NIH's project files
See all 572 nih grantsPapers1,312
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to "The importance of hsa-miR-28 in human malignancies" [Biomed. Pharmacother. 161 (2023) 114453]. | Biomed Pharmacother | 2026 | 42070926 | PubTator, text mining | PubMed |
| Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. | Leukemia | 2026 | 41951939 | PubTator, text mining | PubMed |
| Advances in the study of nucleolar small RNAs in colorectal cancer. | iScience | 2026 | 41732269 | PubTator, text mining | PubMed |
| microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2. | Mol Ther Nucleic Acids | 2026 | 41717286 | PubTator, text mining | PubMed |
| Transposable Element-Derived miR-28-5p and miR-708-5p: Exploring Potential Roles in Lung Cancer. | Noncoding RNA | 2025 | 41441397 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| MicroRNAs and lung cancer: overview of essential pathways and somatic mutations in cancer progression. | Front Oncol | 2025 | 41127014 | PubTator, text mining | PubMed |
| Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. | Front Cell Dev Biol | 2025 | 40809695 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| miR-28: A Tiny Player in Cancer Progression and Other Human Diseases. | Biomolecules | 2025 | 40563399 | PubTator, text mining | PubMed |
1 to 10 of 1,312
See all 1,312 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/407020
GET https://conductscience.org/api/genes/v1/407020/grants?page=2